相关实验视频

Updated: May 21, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K

在丹麦和英格兰,对脆弱的癌症患者进行临床试验参与

Lars Hernández Nielsen1, Jakob Bruhn Krøjgaard Skelmose2, Laurids Østergaard Poulsen3

  • 1Center for Clinical Data Science, Department of Clinical Medicine, Aalborg University, and Research, Education and Innovation, Aalborg University Hospital, Denmark; Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Denmark.

Cancer epidemiology
|March 19, 2025
PubMed
概括

丹麦和英格兰的脆弱癌症患者在临床试验中的参与减少,特别是对于妇科癌症. 这突出了访问障碍,并影响了试验的通用性.

关键词:
参加临床试验的参与.医疗保健中的差异医疗保健中的不平等胰腺癌是一种癌症.

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

11.9K

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
72